IE37596B1 - 21-substituted 3alpha-hydroxy pregnanes - Google Patents
21-substituted 3alpha-hydroxy pregnanesInfo
- Publication number
- IE37596B1 IE37596B1 IE709/73A IE70973A IE37596B1 IE 37596 B1 IE37596 B1 IE 37596B1 IE 709/73 A IE709/73 A IE 709/73A IE 70973 A IE70973 A IE 70973A IE 37596 B1 IE37596 B1 IE 37596B1
- Authority
- IE
- Ireland
- Prior art keywords
- alpha
- substituted
- 3alpha
- hydroxy
- additionally
- Prior art date
Links
- -1 azide ions Chemical class 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 abstract 1
- 230000003444 anaesthetic effect Effects 0.000 abstract 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 125000004043 oxo group Chemical group O=* 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2114272A GB1430942A (en) | 1972-05-05 | 1972-05-05 | 21-substituted 3alpha-hydroxy pregnanes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE37596L IE37596L (en) | 1973-11-05 |
| IE37596B1 true IE37596B1 (en) | 1977-08-31 |
Family
ID=10157915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE709/73A IE37596B1 (en) | 1972-05-05 | 1973-05-04 | 21-substituted 3alpha-hydroxy pregnanes |
Country Status (16)
| Country | Link |
|---|---|
| JP (1) | JPS4961150A (en:Method) |
| AT (1) | AT355232B (en:Method) |
| AU (1) | AU475168B2 (en:Method) |
| BE (1) | BE799102A (en:Method) |
| CA (1) | CA1013341A (en:Method) |
| CH (1) | CH617710A5 (en:Method) |
| DE (1) | DE2322532A1 (en:Method) |
| ES (1) | ES414411A1 (en:Method) |
| FR (1) | FR2183792B1 (en:Method) |
| GB (1) | GB1430942A (en:Method) |
| IE (1) | IE37596B1 (en:Method) |
| IL (1) | IL42196A (en:Method) |
| LU (1) | LU67546A1 (en:Method) |
| NL (1) | NL7306234A (en:Method) |
| SE (1) | SE400771B (en:Method) |
| ZA (1) | ZA733035B (en:Method) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5232917A (en) * | 1987-08-25 | 1993-08-03 | University Of Southern California | Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
| US5939545A (en) | 1994-02-14 | 1999-08-17 | Cocensys, Inc. | Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series |
| PT752860E (pt) * | 1994-02-14 | 2000-12-29 | Euro Celtique Sa | Androstanos e pregnanos para modulacao alosterica do receptor de gaba |
| GR1003861B (el) * | 2000-12-29 | 2002-04-11 | Νεα νευροστεροειδη που αλληλεπιδρουν με τον υποδοχεα gabaa. | |
| JP4915427B2 (ja) * | 2009-03-30 | 2012-04-11 | ブラザー工業株式会社 | 液体供給ジョイント、これを使用した液体吐出ヘッド及び記録装置 |
| EP3572417A3 (en) | 2011-10-14 | 2020-03-25 | Sage Therapeutics, Inc. | 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof |
| PL2806877T3 (pl) | 2012-01-23 | 2020-06-01 | Sage Therapeutics, Inc. | Formulacje neuroaktywnego steroidu zawierające kompleks allopregnanolonu i eteru sulfobutylowego beta-cyklodekstryny |
| RS62761B1 (sr) | 2012-08-21 | 2022-01-31 | Sage Therapeutics Inc | Alopregnanolon za lečenje refraktornog epileptičkog statusa |
| MX395023B (es) | 2013-04-17 | 2025-03-24 | Sage Therapeutics Inc | Esteroides c21-n-pirazolilo 19-nor c3,3-disustituidos y metodos de uso de los mismos. |
| WO2014169836A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor neuroactive steroids and methods of use thereof |
| WO2014169831A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof |
| PT2986624T (pt) | 2013-04-17 | 2020-07-07 | Sage Therapeutics Inc | Esteroides neuroativos 19-nor para métodos de tratamento |
| RU2754534C2 (ru) | 2013-07-19 | 2021-09-03 | Сейдж Терапьютикс, Инк. | Нейроактивные стероиды, композиции и их использование |
| BR112016003862B1 (pt) | 2013-08-23 | 2022-09-06 | Sage Therapeutics, Inc | Compostos esteroides neuroativos, suas composições e seus usos |
| US10246482B2 (en) | 2014-06-18 | 2019-04-02 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| JOP20200195A1 (ar) | 2014-09-08 | 2017-06-16 | Sage Therapeutics Inc | سترويدات وتركيبات نشطة عصبياً، واستخداماتها |
| US20170233433A1 (en) | 2014-10-16 | 2017-08-17 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| CN107404877A (zh) | 2014-10-16 | 2017-11-28 | 萨奇治疗股份有限公司 | 靶向cns 障碍的组合物和方法 |
| HRP20200840T1 (hr) | 2014-11-27 | 2020-11-13 | Sage Therapeutics, Inc. | Pripravci i postupci za liječenje poremećaja cns-a |
| HUE054092T2 (hu) | 2015-01-26 | 2021-08-30 | Sage Therapeutics Inc | Központi idegrendszeri zavarok kezelésére szolgáló kompozíciók és eljárások |
| US10329320B2 (en) | 2015-02-20 | 2019-06-25 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| TW202400182A (zh) | 2016-03-08 | 2024-01-01 | 美商賽吉醫療公司 | 神經活性類固醇，其組合物及用途 |
| EP4302764A3 (en) | 2016-07-11 | 2024-06-26 | Sage Therapeutics, Inc. | C17, c20, and c21 substituted neuroactive steroids and their methods of use |
| CA3030420A1 (en) | 2016-07-11 | 2018-01-18 | Sage Therapeutics, Inc. | C7, c12, and c16 substituted neuroactive steroids and their methods of use |
| JOP20210293A1 (ar) | 2019-05-31 | 2023-01-30 | Sage Therapeutics Inc | ستيرويدات ذات فعالية عصبية وتركيبات منها |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1346292A (fr) * | 1962-09-14 | 1963-12-20 | Roussel Uclaf | Nouveau procédé de préparation des 21-amino stéroïdes |
| US3144446A (en) * | 1963-12-20 | 1964-08-11 | Upjohn Co | Mono and bis nu-(3alpha, 17alpha-dihydroxy-11, 20-dioxo-5beta-pregnan-21-yl) quaternary ammonium salts of triethylenediamine |
-
1972
- 1972-05-05 GB GB2114272A patent/GB1430942A/en not_active Expired
-
1973
- 1973-05-04 ZA ZA733035A patent/ZA733035B/xx unknown
- 1973-05-04 LU LU67546A patent/LU67546A1/xx unknown
- 1973-05-04 AT AT395173A patent/AT355232B/de not_active IP Right Cessation
- 1973-05-04 CH CH636073A patent/CH617710A5/de not_active IP Right Cessation
- 1973-05-04 BE BE130749A patent/BE799102A/xx unknown
- 1973-05-04 CA CA170,482A patent/CA1013341A/en not_active Expired
- 1973-05-04 NL NL7306234A patent/NL7306234A/xx not_active Application Discontinuation
- 1973-05-04 IE IE709/73A patent/IE37596B1/xx unknown
- 1973-05-04 FR FR7316108A patent/FR2183792B1/fr not_active Expired
- 1973-05-04 JP JP48050183A patent/JPS4961150A/ja active Pending
- 1973-05-04 ES ES0414411A patent/ES414411A1/es not_active Expired
- 1973-05-04 AU AU55284/73A patent/AU475168B2/en not_active Expired
- 1973-05-04 DE DE2322532A patent/DE2322532A1/de not_active Ceased
- 1973-05-04 SE SE7306330A patent/SE400771B/xx unknown
- 1973-05-04 IL IL42196A patent/IL42196A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU5528473A (en) | 1974-11-07 |
| FR2183792B1 (en:Method) | 1977-07-15 |
| AT355232B (de) | 1980-02-25 |
| BE799102A (fr) | 1973-11-05 |
| FR2183792A1 (en:Method) | 1973-12-21 |
| GB1430942A (en) | 1976-04-07 |
| AU475168B2 (en) | 1976-08-12 |
| ZA733035B (en) | 1974-04-24 |
| ATA395173A (de) | 1979-07-15 |
| IE37596L (en) | 1973-11-05 |
| DE2322532A1 (de) | 1973-11-22 |
| JPS4961150A (en:Method) | 1974-06-13 |
| IL42196A (en) | 1978-10-31 |
| SE400771B (sv) | 1978-04-10 |
| NL7306234A (en:Method) | 1973-11-07 |
| IL42196A0 (en) | 1973-07-30 |
| LU67546A1 (en:Method) | 1973-07-13 |
| CH617710A5 (en) | 1980-06-13 |
| ES414411A1 (es) | 1976-02-01 |
| CA1013341A (en) | 1977-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE37596B1 (en) | 21-substituted 3alpha-hydroxy pregnanes | |
| IE38617L (en) | 11, 11-alkylidene steroids. | |
| GB1418003A (en) | Fasteners | |
| CA1016535A (en) | .delta. 8,9 steroids of the pregnane series | |
| GB1187660A (en) | Fluoroformates of Steroid 17-beta-Ols | |
| IE37597B1 (en) | 21-fluoro-pregnanes | |
| GB1419216A (en) | Oleandrin derivative | |
| GB1182283A (en) | Process for the Manufacture of 15,16beta-Methylene-Steroids | |
| CA815065A (en) | N-PROPYL-13.beta. BIS NOR-18,19 SECO-4,5 PREGNANE, PREGNENE ET PREGNADIENE | |
| GB1131445A (en) | Novel steroids | |
| IE38899L (en) | Pyridine derivatives. | |
| NZ182865A (en) | 2.9 -dichloro-6 -fluoro-16 -methyl-11 ,17 , 21-trihydroxy-pregna-1,4-diene-3,20-diones | |
| CA859136A (en) | 16-ALKYL-11-OXYGENATED-4-PREGNENE-17.alpha.-OL-3,20-DIONE AND THE CORRESPONDING 1,4-PREGNADIENE COMPOUNDS | |
| CA969175A (en) | 6.alpha.,9.alpha.-DIFLUOROSTEROIDS OF THE PREGNANE SERIES AND PROCESSES FOR THEIR MANUFACTURE | |
| CA863337A (en) | .DELTA.1,4-PREGNADIENE-17.alpha.,21-DIOL-3,11,20-TRIONE | |
| IE36373B1 (en) | Substituted benzimidazolecarbamates and tautomers thereof | |
| CA857869A (en) | 6.alpha.,16.beta.-DIMETHYL-11-OXYGENATED-4-PREGNENE-17.alpha.,21-DIOL-3,20-DIONES | |
| CA700410A (en) | METHOD OF PREPARING SUBSTITUTED 21-SULFONYLOXY-16.alpha.,17.alpha.-DIHYDROXY STEROIDS OF THE PREGNANE SERIES | |
| CA684358A (en) | 3-oxatricyclo (3.2.1.02,4) octane-6,7-diol and the cyclic carbonate thereof | |
| AU452240B2 (en) | 21 fluoro-16, 17-dihydroxy pregnane compounds and their derivatives | |
| CA880871A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING 6-METHYL-16-METHYLENE-17.alpha.-HYDROXY-4,6-PREGNADIENE-3,20-DIONE 17-ACETATE | |
| CA972350A (en) | 1,2-METHYLENE-17.alpha.-ACYLOXY(OR IMPROVED HYDROXY)-9.beta.,10.alpha.-STEROID COMPOUNDS OF THE PREGNANE SERIES, PHARMACEUTIC PREPARATIONS OF THE BASIS OF THE NOVEL COMPOUNDS AND METHODS OF PRODUCING SAID COMPOUNDS AND PREPARATIONS | |
| GB1285263A (en) | IMPROVEMENTS IN OR RELATING TO 6alpha,6beta-DIFLUORO STEROIDS | |
| FR2031806A5 (en) | 17beta-spiro-oxiranes of the oestrane series | |
| AU2774371A (en) | 21 fluoro-16, 17-dihydroxy pregnane compounds and their derivatives |